Why the Nova Eye (ASX:EYE) share price is surging 7% higher

The Nova Eye (ASX: EYE) share price is up 7.5% today following the publication of its LEAD trial results. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nova Eye Medical Ltd (ASX: EYE) share price is in the green today. This comes after the company released positive results showing the efficacy of its 2RT treatment.

During mid-afternoon trade, the medical technology company's shares are up 7.58% to 36 cents.

What were the results?

In today's release, Nova Eye advised that it has published the results of its 5-year patient follow-up data from the LEAD trial in a recent publication of Ophthalmology Retina. The article discusses the long-term effect of subthreshold nanosecond laser (SNL) treatment on progression to late age-related macular degeneration (AMD).

The company said the LEAD trial was a randomised, controlled multi-centre study involving 292 patients over a 6-year period (2012 to 2018). The program assessed the efficacy of 2RT at the 3-year mark in patients suffering from intermediate AMD.

Of the enrolled patients that completed the 5-year review (222 patients), two groups were equally split. This consisted of the 2RT treatment group, and the other being the non-treatment group.

The published article states that when factoring the trial participants and additional data observed during the five-year post-LEAD review, the results are promising. It showed strong evidence of a reduction in the rate of progression in AMD when treated with 2RT.

What did management say?

Nova Eye Medical director Tom Spurling hailed the results, saying:

While these data have been calculated by the authors using post-hoc analysis, the improvement in the clinical response in patients without RPD at five years using is very exciting, particularly given these patients did not receive further 2RT treatment during the last two- year observation period.

Overall, there was a significant reduction in the rate of progression to late-stage AMD in these patients. This is of significant benefit to patients in deferring disease progression and thus maintaining their quality of life. It also supports our previously stated position that 2RT offers the potential to meet a major global unmet need to delay onset of blindness.

About the Nova Eye share price

The Nova Eye share price has lost almost half of its value since this time last year. The company's shares have been impacted by COVID-19, which has affected its medical equipment and devices business.

Based on the current share price, Nova Eye Medical commands a market capitalisation of close to $50 million.

Should you invest $1,000 in Visa right now?

Before you buy Visa shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Visa wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Nova Eye Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A head shot of legendary investor Warren Buffett speaking into a microphone at an event.
Share Market News

Warren Buffett to retire: A historic changing of the guard at Berkshire Hathaway

It is an end of era for investors with this big news.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

A corporate man crosses his arms to make an X, indicating no deal.
Opinions

How to invest: my 3 biggest ASX share dealbreakers

I want to avoid certain things with my investing.

Read more »

hands holding up winners cup, asx 200 winning shares
Share Market News

Guess which stock just became the world's most valuable company?

There's a new sheriff (back) in town.

Read more »

Happy man working on his laptop.
Share Market News

5 things to watch on the ASX 200 on Monday

The local market looks set to have a positive start to the week.

Read more »

a woman holds her hands up in delight as she sits in front of her lap
Share Market News

US jobs report ignites market rally. What could move the needle this week?

All eyes on the Federal Reserve.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Opinions

Why I think these 2 ASX shares are bargain buys

I like the value offered by these stocks.

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Opinions

My favourite ASX 200 stock in my portfolio right now

This business has a lot going for it, in my opinion.

Read more »